Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instant Technologies is a leading developer and distributor of rapid point-of-care diagnostic products, primarily focused on the toxicology and drugs-of-abuse testing markets. Headquartered in Norfolk, Virginia, the company is widely recognized for its proprietary "i-Cup" and "i-Screen" integrated testing devices, which allow for simultaneous collection and rapid immunoassay screening of multiple drug classes with built-in adulteration detection. In 2007, the company was acquired by Inverness Medical Innovations (now Alere, a subsidiary of Abbott Laboratories) for approximately $43.7 million. Today, Instant Technologies continues to operate as a key manufacturing and distribution hub within Abbott's Rapid Diagnostics division, providing essential testing solutions for workplace, criminal justice, and clinical environments globally. Its technology is characterized by high accuracy, ease of use, and rapid results, supporting global efforts in substance abuse monitoring and public health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instant Technologies.